No Data
No Data
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback?
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
IDEXX Laboratories' (NASDAQ:IDXX) Earnings Growth Rate Lags the 9.3% CAGR Delivered to Shareholders
Unusual Options Activity: NVT, IDXX and Others Attract Market Bets, NVT V/OI Ratio Reaches 238.0
EST Dec 18th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $559
No Data